Literature DB >> 7912701

Relevant psychometric tests for antidepressants and anxiolytics.

I Hindmarch1.   

Abstract

Psychometric tests can provide a sensitive and objective measure of drug effects which are of relevance to the clinical situation. Two tests, critical flicker fusion threshold and choice reaction time, used alone or as a part of a battery of tests, have been shown to be useful in detecting differences between drugs in their effect on cognitive and psychomotor functions. They provide important information on the activity and safety of drugs as they are used in practice.

Mesh:

Substances:

Year:  1994        PMID: 7912701     DOI: 10.1097/00004850-199403001-00005

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  4 in total

1.  A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.

Authors:  Ian Hindmarch; Leanne Trick; Fran Ridout
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

2.  A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.

Authors:  Ian Hindmarch; Eric Legangneux; Neil Stanley; Steve Emegbo; Jean Dawson
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

3.  Cognitive performance in depressed patients after chronic use of antidepressants.

Authors:  Clarice Gorenstein; Stefania Caldeira de Carvalho; Rinaldo Artes; Ricardo Alberto Moreno; Tania Marcourakis
Journal:  Psychopharmacology (Berl)       Date:  2006-02-17       Impact factor: 4.530

4.  Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial.

Authors:  Victoria L Revell; Ciro Della Monica; Jeewaka Mendis; Hana Hassanin; Robin J Halter; Sandra R Chaplan; Derk-Jan Dijk
Journal:  Neuropsychopharmacology       Date:  2021-10-09       Impact factor: 7.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.